We are monitoring the impact of COVID-19 on APAC Methadone Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 6497
Share on
Share on

Asia Pacific Methadone Market Research Report - Segmented By Application, Mode Of Administration & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 6497
Pages: 145

Asia Pacific Methadone Market Size & Growth (2021 to 2026):

As per the research report, the size of the Asia Pacific Methadone Market was valued at USD xx Million in 2021 and estimated to be growing at a CAGR of xx%, to reach USD xx Million by 2026 during the forecast period 2021 to 2026.

The market's growth is driven by the increase in the incidence of accidents, orthopedic diseases, and other chronic pain disorders. In addition, increasing disposable income, drug abuse, toxicity, and the rising geriatric population will drive the growth of the studied market. Methadone reduces withdrawal symptoms in people who use heroin or other drugs. Methadone is an excellent alternative to morphine sulfate and other opioid pain relievers due to its long half-life and low patient risk value. All of these factors support the burgeoning APAC methadone market.

Additionally, the market is strongly influenced by methadone maintenance therapy, which involves long-term use of the methadone formulation in opioid-dependent patients such as fentanyl, heroin, hashish, etc. In 2013, there were 2,475,500 registered drug addicts in China, including 1,326,500 heroin addicts, or 53.76% of the drug addict population. Some unofficial estimates reach 12.69 million drug addicts. In India, the use is reported in 2.18% of the total population, with heroin use highest at 1.148%, followed by pharmaceutical opioids with 0.968% and opium with 0.58%. Methadone is used in relieving severe pain in patients who take pain relievers 24 hours a day for a long time and cannot be treated with other drug variants. Methadone for pain management in developing APAC countries is projected to create lucrative opportunities for expanding the market shortly.

The increasing prevalence of emerging pain associated with the therapeutic and post-surgical treatment of cancer and other critical chronic diseases will significantly influence the market.

However, the emergence and legalization of cannabis as an alternative to methadone is hampering the market's growth. Moreover, due to some risks associated with the use of methadone in patients with severe asthma or breathing problems, you may restrict its use, which could slow down the market.

This research report on the APAC Methadone Market has been segmented and sub-segmented into the following categories:

By Application:

  • Operation
  • Detoxification
  • Others

By Mode Of Administration:

  • Injections
  • Oral Medicine

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the Australia methadone market dominated the APAC methadone market with a significant 35% share in 2020. It is due to the increasing incidence of drug addiction and a higher adoption rate of opioid pain relievers.

According to the United Nations Office on Drugs and Crime (UNODC), more than 47,500 people died of opioid overdoses, increasing the demand for methadone which acts as the opioid receptor. In addition, the increase in incidents of opioid abuse and the growing number of people habituated to heroin and other drugs and their treatment, which involves the short-term administration of methadone hydrochloride, only adds to the strong growth in the APAC market.

The Chinese methadone market will outperform all regions with the highest CAGR of 2.56% from 2021 to 2026. Because of population growth and increasing development in the healthcare sector, the increasing number of patients associated with pain and other chronic diseases will boost the market.

According to GLOBOCAN estimates, approximately 4,285,100 new cancer cases were diagnosed in China in 2019, of which 2,366,100 were men and 1,919,050 were women. The crude and age-standardized incidence rates for all cancers were 301.15 and 201.78 per 100,000, respectively.

KEY MARKET PLAYERS

The Top companies leading in the APAC Methadone Market profiled in the report are Diskets, Methadoes, Aurolife Pharma LLC, Macfarlan Smith, VistaPharm, Qinghai Pharm, CentralPharm, Mallinckrodt, and Roxane (Boehringer Ingelheim) among others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods      

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Operation

                                5.1.2 Detoxification        

                                5.1.3 Others      

                                5.1.4  Y-o-Y Growth Analysis, By Application        

                                5.1.5  Market Attractiveness Analysis, By Application      

                                5.1.6  Market Share Analysis, By Application       

                5.2 Mode of Administration                       

                                5.2.1 Injections                

                                5.2.2 Oral Medicine        

                                                5.2.2.1 Tablets

                                                5.2.2.2 Liquid

                                5.2.3 Y-o-Y Growth Analysis, By Mode of Administration               

                                5.2.4 Market Attractiveness Analysis, By Mode of Administration             

                                5.2.5 Market Share Analysis, By Mode of Administration              

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Application

                                                6.1.3.2 By Mode of Administration

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Application

                                                6.1.4.2 By Mode of Administration

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Application

                                                6.1.5.2 By Mode of Administration

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Diskets                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Methadoes                

                8.3 Aurolife Pharma LLC                               

                8.4 Macfarlan Smith                       

                8.5 VistaPharm                 

                8.6 Qinghai Pharm                          

                8.7 CentralPharm                            

                8.8 Mallinckrodt                               

                8.9 Roxane                         

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by mode of administration along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Methadone  Market By Application, From 2021 to 2026 ( USD Million )
  2. Asia Pacific Operation Market By Region, From 2021 to 2026 ( USD Million )
  3. Asia Pacific Detoxification  Market By Region, From 2021 to 2026 ( USD Million )
  4. Asia Pacific Others Market By Region, From 2021 to 2026 ( USD Million )
  5. Asia Pacific Methadone  Market By Mode of Administration, From 2021 to 2026 ( USD Million )
  6. Asia Pacific Injections  Market By Region, From 2021 to 2026 ( USD Million )
  7. Asia Pacific Oral Medicine Market By Region, From 2021 to 2026 ( USD Million )
  8. Japan Methadone  Market By Application, From 2021 to 2026 ( USD Million )
  9. Japan Methadone  Market By Mode of Administration, From 2021 to 2026 ( USD Million )
  10. China Methadone  Market By Application, From 2021 to 2026 ( USD Million )
  11. China Methadone  Market By Mode of Administration, From 2021 to 2026 ( USD Million )
  12. India Methadone  Market By Application, From 2021 to 2026 ( USD Million )
  13. India Methadone  Market By Mode of Administration, From 2021 to 2026 ( USD Million )
  14. Australia Methadone  Market By Application, From 2021 to 2026 ( USD Million )
  15. Australia Methadone  Market By Mode of Administration, From 2021 to 2026 ( USD Million )
  16. South Korea Methadone  Market By Application, From 2021 to 2026 ( USD Million )
  17. South Korea Methadone  Market By Mode of Administration, From 2021 to 2026 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample